Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis
- Resource Type
- Article
- Source
- The Lancet Child & Adolescent Health; January 2023, Vol. 7 Issue: 1 p13-25, 13p
- Subject
- Language
- ISSN
- 23524642; 23524650